Cite
HARVARD Citation
Stuart, L. et al. (2020). Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma. Hepatology. 71 (6), pp. 2164-2166. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stuart, L. et al. (2020). Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma. Hepatology. 71 (6), pp. 2164-2166. [Online].